Experience with long-term use of certolizumab pegol (Cimzia)
Objective: to establish whether long-term combination therapy with a tumor necrosis factor (TNF) α inhibitor and a disease-modifying antirheumatic drug (DMARD) (methotrexate – MTX) may lead to sustained rheumatoid arthritis (RA) remission and its maintenance even after discontinuation of genetically...
Spremljeno u:
| Glavni autori: | , |
|---|---|
| Format: | Artigo |
| Jezik: | Russo |
| Izdano: |
IMA-PRESS LLC
2013-10-01
|
| Serija: | Современная ревматология |
| Teme: | |
| Online pristup: | https://mrj.ima-press.net/mrj/article/view/496 |
| Oznake: |
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|